CONTENTS

Issue 92 | March 2020

In association with

Opioids 2020

What does the next decade have in store for the US opioids crisis? 

precision medicine

Is precision medicine any closer to taking on blanket drug development?

Packaging

Could recyclable unit dose packaging help bolster the green credentials of pharma?

cystic fibrosis

Vertex's Trikafta could be a step in the right direction for cystic fibrosis patients

cannabinoids

Talking innovation with the Association for the Cannabinoid Industry

anti fungal

Resistance to anti-fungal medication presents a serious public health risk

leaks and fraud

Leaks of internal information are the biggest risk facing the life sciences industry

shortages

What is behind the sudden shortage of immune globulin? 

IMDP

Turning attention towards patient benefits with IDMP data standards implementation

02/24/2024 16:33:23
  • Home | The path of yeast resistance
  • NSF
  • Editorial
  • Contents
  • News
  • Emirates SkyCargo
  • The pharma industry briefing
  • A resolution for the new decade: resolve the US opioid crisis
  • Eurofins CDMO
  • Precision medicine: what barriers remain?
  • Can recyclable packaging turn the pharma industry green?
  • Phoenix Company Insight
  • Phoenix
  • Vertex’s Trikafta: treating the genetic basis of cystic fibrosis
  • Accurate Biometrics Company Insight
  • Accurate Biometrics
  • Q&A: talking innovation with the Association for the Cannabinoid Industry
  • Yeast of burden: how to develop better antifungal drugs
  • Loose lips bring risks: protecting pharma against leaks and fraud
  • Why are patients struggling to access life-saving immune globulin?
  • Mimotopes
  • Deals in brief powered by GlobalData
  • Nolato Company Insight
  • Nolato
  • The key list powered by GlobalData
  • Events
  • Next issue
02/21/2020 00:00:00